KROS$10.03-2.62%
Keros Therapeutics, Inc.
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap & EV:$196.83M /
Float & O/S:18.78M / 19.62M
Est. Net Cash/Sh:
Inst Own:97.3%
DilutionScan read 50 of Keros Therapeutics, Inc.'s SEC filings and found 1 ATM program and 3 shelf registrations on file for KROS. The latest dilution event on file is ATM sales on Sep 30, 2026. Analysis updated Nov 16, 2026.